| Siglecs as immune cell checkpoints in disease S Duan, JC Paulson Annual review of immunology 38, 365-395, 2020 | 285 | 2020 |
| CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen S Duan, CJ Koziol-White, WF Jester, SA Smith, CM Nycholat, ... The Journal of clinical investigation 129 (3), 2021 | 89 | 2021 |
| Repression of phagocytosis by human CD33 is not conserved with mouse CD33 A Bhattacherjee, E Rodrigues, J Jung, M Luzentales-Simpson, ... Communications biology 2 (1), 450, 2019 | 67 | 2019 |
| A sulfonamide sialoside analogue for targeting Siglec-8 and-F on immune cells CM Nycholat, S Duan, E Knuplez, C Worth, M Elich, A Yao, J O’Sullivan, ... Journal of the American Chemical Society 141 (36), 14032-14037, 2019 | 46 | 2019 |
| Nanoparticles displaying allergen and Siglec-8 ligands suppress IgE-FcεRI–mediated anaphylaxis and desensitize mast cells to subsequent antigen challenge S Duan, BM Arlian, CM Nycholat, Y Wei, H Tateno, SA Smith, ... The Journal of Immunology 206 (10), 2290-2300, 2021 | 44 | 2021 |
| Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2 KA Orgel, S Duan, BL Wright, SJ Maleki, JC Wolf, BP Vickery, AW Burks, ... Journal of Allergy and Clinical Immunology 139 (1), 366-369. e2, 2017 | 41 | 2017 |
| Human CD22 inhibits murine B cell receptor activation in a human CD22 transgenic mouse model KJ Bednar, E Shanina, R Ballet, EP Connors, S Duan, J Juan, BM Arlian, ... The Journal of Immunology 199 (9), 3116-3128, 2017 | 36 | 2017 |
| Structure, Biochemistry, and Inhibition of Essential 4′-Phosphopantetheinyl Transferases from Two Species of Mycobacteria CR Vickery, NM Kosa, EP Casavant, S Duan, JP Noel, MD Burkart ACS chemical biology 9 (9), 1939-1944, 2014 | 36 | 2014 |
| SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection TY Tsai, MT Huang, PS Sung, CY Peng, MH Tao, HI Yang, WC Chang, ... The Journal of clinical investigation 131 (11), 2021 | 28 | 2021 |
| Antigenic liposomes for generation of disease-specific antibodies KJ Bednar, L Hardy, J Smeekens, D Raghuwanshi, S Duan, MD Kulis, ... JoVE (Journal of Visualized Experiments), e58285, 2018 | 19 | 2018 |
| Suppressing immune responses using Siglec ligand-decorated anti-receptor antibodies M Islam, BM Arlian, F Pfrengle, S Duan, SA Smith, JC Paulson Journal of the American Chemical Society 144 (21), 9302-9311, 2022 | 18 | 2022 |
| Repression of phagocytosis by human CD33 is not conserved with mouse CD33. Commun Biol. 2019; 2 (1): 450 A Bhattacherjee, E Rodrigues, J Jung, M Luzentales-Simpson, ... | 7 | |
| Using Siglec-engaging Tolerance-inducing Antigenic Liposomes (STALs) to reduce memory B cell responses to the major peanut allergen Ara h 2 LKC Hardy, K Orgel, S Duan, SJ Maleki, AW Burks, JC Paulson, ... Journal of Allergy and Clinical Immunology 141 (2), AB200, 2018 | 2 | 2018 |
| Siglec-engaging tolerance-inducing antigenic liposomes (STALs) in the prevention of peanut allergy K Orgel, S Duan, JC Paulson, AW Burks, BP Vickery, MD Kulis, ... Journal of Allergy and Clinical Immunology 137 (2), AB89, 2016 | 1 | 2016 |
| Immune cell receptor antibodies conjugated to high affinity siglec-ligands JC Paulson, M Islam, F Pfrengle, M Macauley, S Duan, B Arlian US Patent App. 17/755,382, 2023 | | 2023 |
| Desensitizing mast cells by co-presentation of antigens with high affinity mast cell siglec ligands JC Paulson, S Duan, M Macauley, C Nycholat US Patent 10,994,006, 2021 | | 2021 |
| Development of high-affinity glycan analog ligands of siglecs and galectins C Nycholat, S Duan, S Willis, E Wamhoff, C Arthur, R McBride, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
| Exploiting Siglecs to Treat Allergic Diseases S Duan The Scripps Research Institute, 2019 | | 2019 |
| Exploiting Inhibitory Siglecs to Combat Allergies S Duan Scripps Research Institute, 2019 | | 2019 |
| Exploiting siglecs to modulate immune responses J Paulson, B Arlian, S Duan, L Edgar, C Kikuchi, M Macauley, ... FEBS OPEN BIO 8, 46-46, 2018 | | 2018 |
